Blar i St. Olavs hospital på tidsskrift "Translational Neurodegeneration"
Viser treff 1-1 av 1
-
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers
(Peer reviewed; Journal article, 2020)Background: Asymptomatic carriers of leucine-rich repeat kinase 2 (LRRK2) gene mutations constitute an ideal population for discovering prodromal biomarkers of Parkinson's disease (PD). In this study, we aim to identify ...